Harvey Brandwein

Title: Harvey Brandwein: Innovator in Immunotherapy

Introduction

Harvey Brandwein is a notable inventor based in East Hills, NY (US). He has made significant contributions to the field of immunotherapy, particularly in the treatment of human papillomavirus (HPV) infections. With a total of 7 patents to his name, Brandwein's work is paving the way for innovative therapeutic approaches.

Latest Patents

Brandwein's latest patents focus on methods of immunotherapy for the treatment of HPV. One of his key inventions involves administering a therapeutically effective amount of a primary cell-derived biologic to patients infected with HPV, which induces an immune response to the virus. Another patent addresses overcoming HPV-induced immune suppression of Langerhans cells (LC) by activating these cells through similar biologic administration. Additionally, he has developed methods to increase LC migration towards lymph nodes and generate immunity against HPV, ultimately preventing new lesions from developing.

Career Highlights

Throughout his career, Harvey Brandwein has worked with prominent companies such as Irx Therapeutics, Inc. and Pall Corporation. His experience in these organizations has contributed to his expertise in immunotherapy and the development of innovative treatment methods.

Collaborations

Brandwein has collaborated with notable professionals in his field, including James E. Egan and John W. Hadden. These partnerships have further enhanced his research and development efforts in immunotherapy.

Conclusion

Harvey Brandwein's contributions to immunotherapy and his innovative patents demonstrate his commitment to advancing medical science. His work continues to impact the treatment of HPV and offers hope for improved patient outcomes.